Skip to main content
Premium Trial:

Request an Annual Quote

Washington State Awards $15M to Sage, Hutch, U Wash

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Washington State's Life Sciences Discovery Fund has awarded $15 million to Sage Bionetworks, the University of Washington, and the Fred Hutchinson Cancer Research Center.

The Seattle-based funding branch of the Washington State government said that the collaborative research initiatives will enhance the diagnosis and treatment of cancer and other major diseases.

Sage Bionetworks, a non-profit research organization focused on creating open-access disease-modeling tools, will use its $5 million grant to develop a computing infrastructure to deliver scalable network data models and analyses to collaborators. Sage will also use the funding to create the Washington Partners Program, which will engage academic and biotechnology communities in systems biology research.

Thomas Matula, a physics and engineering researcher at the University of Washington, will use his $5 million grant to develop, translate, and commercialize new ultrasound techniques for use in molecular imaging and therapy.

Using ultrasound tools in combination with advanced molecular approaches could enable clinicians to target specific molecules in tissues for more precise imaging and for drug delivery. This award will also create the Washington Molecular Imaging and Therapy Center, which will develop and commercialize these new ultrasound tools.

Fred Hutchinson researcher Peggy Porter will use her $5 million award to develop a biospecimen collection and distribution system that links regional investigators with specimens. Porter’s lab will host the Consortium Biospecimen Program, which will include a cross-institution informatics platform and standardized practices for transferring materials and managing intellectual property.

This program will use resources already funded by LSDF, including the Phase 1 Clinical Trials Program and the Northwest Institute of Genetic Medicine. The consortium includes the Fred Hutchinson Cancer Research Center, the University of Washington, and Seattle Children’s Hospital and Research Institute.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.